Purpose: We assessed the quality of randomized, controlled trial reporting in abstracts from the annual meetings of the American Urological Association and determined whether the information provided is consistent with subsequent full text publications.

Materials And Methods: All randomized, controlled trials presented in abstract form at the 2002 and 2003 American Urological Association annual meetings were identified for review. A systematic PubMed search based on authorship and key words from the study title was done to identify all subsequent full text publications. A standardized evaluation form was developed based on the published literature, pilot tested in a separate sample and applied by 2 independent reviewers.

Results: A total of 126 randomized, controlled trials were identified for review, including 56 in 2002 and 70 in 2003. Approximately a third of the trials (43 or 34.1%) identified the study design as a randomized, controlled trial in the abstract title. The method of randomization, allocation concealment and blinding was reported in 0% (0), 0% (0) and 40.5% (51) of studies, respectively. Mean/median followup was provided in 27.0% of studies (34). Of 126 randomized, controlled trials presented in abstract form 62.7% (79) were subsequently published as full text articles. Study sample size and the number of randomized subjects differed in 24.1% and 28.9% of abstracts, respectively. From the small proportion of randomized, controlled trials (23 or 29.1%) that identified a single primary end point results differed in 9 of 23 (39.1%).

Conclusions: Most abstracts fail to provide the necessary information to assess methodological quality. Organizers of urological meetings should consider implementing a more structured abstract format that requires authors to provide the necessary study details, thereby allowing urologists to critically appraise study validity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2010.03.045DOI Listing

Publication Analysis

Top Keywords

randomized controlled
28
controlled trials
20
trials presented
12
american urological
12
urological association
12
annual meetings
12
full text
12
randomized
8
association annual
8
controlled trial
8

Similar Publications

Background: Autistic people commonly have physical and mental health conditions. They also frequently experience barriers to accessing healthcare, contributing to problems identifying and treating health conditions. These factors may lead to increased and earlier morbidity and lower average life expectancy for autistic people.

View Article and Find Full Text PDF

Objective: Ankle osteoarthritis is a debilitating condition that significantly impairs patients' quality of life. Platelet-rich plasma has emerged as a novel cellular therapy in clinical practice. This study evaluates the clinical efficacy of platelet-rich plasma (PRP) after intervention in ankle disorders, so as to provide strong evidence in support of clinical treatment.

View Article and Find Full Text PDF

Background: Fibromyalgia (FM) is a generalized, widespread chronic pain disorder affecting 2.7% of the general population. In recent years, different studies have observed a strong association between FM and psychological trauma.

View Article and Find Full Text PDF

Background: There are limited and controversial findings concerning ovulation induction using intrauterine and intramuscular human chorionic gonadotropin (hCG) injection compared to intramuscular hCG alone. The study aimed to examine the impact of intrauterine hCG injection, which is used to induce ovulation, on the efficacy of the intrauterine insemination (IUI) technique in patients with unexplained infertility.

Methods: A randomized controlled clinical trial was conducted involving 80 subjects with unexplained primary infertility at the infertility clinic of Al-Zahra Hospital in northwest Iran.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!